PMS12 Healthcare Costs and Insurance Coverage of Rheumatoid Arthritis Patients in the United States: A 2018 Medical Expenditure Panel Survey Data Analysis

To determine burden of healthcare costs on patients with rheumatoid arthritis (RA) in the US within MEPS 2018 data and to characterize impact sociodemographic insurance coverage. A retrospective, cross-sectional analysis Medical Expenditure Panel Survey (MEPS) was conducted. 456 (1.5%) adult RA were identified from 30,461 survey respondents. Association annual total expenditure characteristics including age, gender, race, coverage calculated. provides a breakdown into prescription medicines, office-based visits, emergency room hospital inpatient stays, outpatient visits physicians. Variations cost components by also analyzed. Average all-cause for has increased over 37% last decade [$13,000 2008 (Kawatkar et al 2012) $17,800 2018]. No significant differences expenditures found between types. Medicare Medicaid covered 54% while private 45%. major payor hospitalization (60%), physician (42%) (54.1%). Private followed as next key payer all resource utilization categories. out pocket (OOP) physicians $574, $104, $18, $10, $20, respectively. OOP showed race. The increase direct health care past is indicative rise well innovation treatment modalities. continues bear majority patients, insurance.